Abivax SA American Depositary Shares - Asset Resilience Ratio

Latest as of March 2026: 2.58%

Abivax SA American Depositary Shares (ABVX) has an Asset Resilience Ratio of 2.58% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ABVX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$14.13 Million

Cash + Short-term Investments

Total Assets

$547.14 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Abivax SA American Depositary Shares's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ABVX total asset value.

Liquid Assets Composition Over Time

This chart breaks down Abivax SA American Depositary Shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Abivax SA American Depositary Shares (ABVX) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$14.13 Million	2.58%
Total Liquid Assets	$14.13 Million	2.58%

Asset Resilience Insights

Limited Liquidity: Abivax SA American Depositary Shares maintains only 2.58% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Abivax SA American Depositary Shares Industry Peers by Asset Resilience Ratio

Compare Abivax SA American Depositary Shares's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS F:A71	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Kailera Therapeutics, Inc. Common Stock NASDAQ:KLRA	Biotechnology	64.92%
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	Biotechnology	78.22%
Beijing Hotgen Biotech Co Ltd SHG:688068	Biotechnology	20.87%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Lexicon Pharmaceuticals Inc NASDAQ:LXRX	Biotechnology	49.32%

Annual Asset Resilience Ratio for Abivax SA American Depositary Shares (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Abivax SA American Depositary Shares.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.34%	$13.69 Million	$584.09 Million	+2.28pp
2024-12-31	0.07%	$136.00K	$205.23 Million	-2.70pp
2023-12-31	2.77%	$9.05 Million	$327.06 Million	+2.76pp
2022-12-31	0.01%	$6.00K	$75.54 Million	+0.00pp
2021-12-31	0.01%	$6.00K	$109.23 Million	0.00pp
2020-12-31	0.01%	$6.00K	$71.30 Million	0.00pp
2019-12-31	0.01%	$6.00K	$51.73 Million	-9.25pp
2018-12-31	9.26%	$5.01 Million	$54.05 Million	-18.89pp
2017-12-31	28.15%	$15.15 Million	$53.81 Million	+3.32pp
2016-12-31	24.84%	$15.05 Million	$60.60 Million	+6.48pp
2015-12-31	18.36%	$14.00 Million	$76.27 Million	+13.87pp
2014-12-31	4.49%	$1.70 Million	$37.97 Million	+3.45pp
2013-12-31	1.04%	$400.00K	$38.46 Million	--

pp = percentage points

About Abivax SA American Depositary Shares

NASDAQ:ABVX USA Biotechnology

Market Cap

$7.95 Billion

Market Cap Rank

#2645 Global

#959 in USA

Share Price

$91.06

Change (1 day)

-4.02%

52-Week Range

$72.50 - $145.31

All Time High

$145.31